Author

Tonya J Webb

University of Maryland, Baltimore - Cited by 2,439 - Cancer Immunology

Biography

Dr. Webb is a leading immunologist and research scientist who is recognized for her studies focused on the modulation of CD1d-mediated NKT cell activation for cancer immunotherapy using natural and artificial platforms.
Title
Cited by
Year
Mechanisms of immune evasion in breast cancer
JP Bates, R Derakhshandeh, L Jones, TJ WebbBMC cancer 18, 1-14, 2018201
209
2018
69
2016
Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection
IV Tiper, JE East, PB Subrahmanyam, TJ WebbFEMS Pathogens and Disease 74 (6), ftw063, 2016201
37
2016
VEGF potentiates GD3-mediated immunosuppression by human ovarian cancer cells
IV Tiper, SM Temkin, S Spiegel, SE Goldblum, RL Giuntoli, M Oelke, ...Clinical Cancer Research 22 (16), 4249-4258, 2016201
35
2016
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
IV Tiper, TJ WebbCancer Immunology, Immunotherapy 65, 1411-1421, 2016201
32
2016
Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses
TJ Webb, GB Carey, JE East, W Sun, DR Bollino, AS Kimball, ...FEMS Pathogens and Disease 74 (6), ftw055, 2016201
29
2016
Immunotherapeutic strategies targeting natural killer T cell responses in cancer
SC Shissler, DR Bollino, IV Tiper, JP Bates, R Derakhshandeh, TJ WebbImmunogenetics 68, 623-638, 2016201
26
2016
The ins and outs of type I iNKT cell development
SC Shissler, TJ WebbMolecular immunology 105, 116-130, 2019201
22
2019
Mixed signals: co-stimulation in invariant natural killer T cell-mediated cancer immunotherapy
SC Shissler, MS Lee, TJ WebbFrontiers in immunology 8, 1447, 2017201
18
2017
Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype
R Derakhshandeh, S Sanadhya, KL Han, H Chen, O Goloubeva, TJ Webb, ...Oncotarget 9 (13), 11126, 2018201
15
2018
NKT Cells in cancer immunotherapy
TJ Webb, W Yuan, E Meyer, P DellabonaFrontiers in Immunology 11, 1314, 2020202
12
2020
Soluble Sema4D in plasma of head and neck squamous cell carcinoma patients is associated with underlying non-inflamed tumor profile
RH Younis, I Ghita, M Elnaggar, R Chaisuparat, VI Theofilou, D Dyalram, ...Frontiers in Immunology , 596646, 2021202
12
2021
Targeting natural killer T cells in solid malignancies
Z Ingram, S Madan, J Merchant, Z Carter, Z Gordon, G Carey, TJ WebbCells 10 (6), 1329, 2021202
11
2021
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...Journal for immunotherapy of cancer 4, 1-106, 2016201
8
2016
Effective barriers: the role of NKT cells and innate lymphoid cells in the gut
C Cairo, TJ WebbThe Journal of Immunology 20 (2), 235-246, 2022202
8
2022
6
2020
Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor
P Humeniuk, S Geiselhart, C Battin, T Webb, P Steinberger, W Paster, ...Scientific reports 9 (1), 7426, 2019201
5
2019
Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes
Semaphorin D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytesRH Younis, KL Han, T WebbJournal for ImmunoTherapy of Cancer 3 (Suppl 2), P280, 2015201
4
2015